STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.
Opening excerpt (first ~120 words) tap to expand
STAT PlusPharma As the U.S. looks on, European countries feel growing pressure on drug prices Two of the region’s biggest economies are taking divergent approaches Manage alerts for this article Email this article Share this article A patient’s health card is put in a reader at a pharmacy in Berlin during a demonstration of a new process for issuing an “e-prescription.”ANNEGRET HILSE/POOL/AFP via Getty Images By Andrew JosephJune 10, 2026 Europe Correspondent Andrew Joseph[email protected]Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at STAT.
Discussion
0 commentsMore from STAT
